Because of the aging human population and increased numbers of surgical procedures
being performed, there is a growing number of biomedical devices being implanted each …

Deep brain stimulation (DBS) of 3 different targets is the most important therapeutic
innovation of the past 30 years for patients with fluctuating Parkinson's disease (PD) …

Parkinson's disease (PD) is a gradually worsening neurodegenerative disorder affecting the
nervous system, marked by a slow progression and varied symptoms. It is the second most …

Parkinson's disease (PD) is a neurodegenerative illness and has a common onset between
the ages of 55 and 65 years. There is progressive development of both motor and non-motor …

Brain stimulation is a critical technique in neuroscience research and clinical application.
Traditional transcranial brain stimulation techniques, such as transcranial magnetic …

Deep brain stimulation (DBS) is used for the treatment of movement disorders, including
Parkinson's disease, dystonia, and essential tremor, and has shown clinical benefits in other …

Parkinson's disease symptoms are most often charted using the MDS-UPDRS. Limitations of
this approach include the subjective character of the assessments and a discrepant …

Deep brain stimulation has developed into an established treatment for movement disorders
and is being actively investigated for numerous other neurological as well as psychiatric …

Parkinson's disease (PD) is characterized by the severe loss of dopaminergic neurons in the
substantia nigra pars compacta, leading to motor dysfunction. The onset of PD is often …

Background: The Medtronic “Percept” is the first FDA-approved deep brain stimulation (DBS)
device with sensing capabilities during active stimulation. Its real-world signal-recording …